Document Classification

Section Type: RESULTS

Text: The placebo-corrected mean (95 % confidence interval) change in HbA1c from baseline (8. 7 %) to week 24 was -1. 7 % (-2. 0, -1. 4) for linagliptin + high-dose metformin, -1. 3 % (-1. 6, -1. 1) for linagliptin + low-dose metformin, -1. 2 % (-1. 5, -0. 9) for high-dose metformin, -0. 8 % (-1. 0, -0. 5) for low-dose metformin and -0. 6 (-0. 9, -0. 3) for linagliptin (all p < 0. 0001).